EMA: Concept paper on the revision of the guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins

27.03.2014

The Guideline on Immunogenicity Assessment of Biotechnology-derived Therapeutic Proteins, CHMP/BMWP/42832/2005 laid down general recommendations for the performance of a systematic immunogenicity assessment from a marketing authorisation perspective.